Positional therapy vs inactive control
Adherence · adults with obstructive sleep apnoea
1 finding from 1 review
- no estimate extracted1 study · 101 participantsLow
Findings
What do systematic reviews say?
259 questions · 260 findings · 27 reviews · Airways
No studies found 22 · 8.5%GRADE not reported 15 · 5.8%Very low 30 · 11.5%Low 99 · 38.1%Moderate 79 · 30.4%High 15 · 5.8%
Positional therapy vs inactive control
Adverse effects Measured as number of participants who discontinued device at end of 2 months · adults with obstructive sleep apnoea
1 finding from 1 review
- no estimate extracted1 study · 101 participantsLow
Positional therapy vs inactive control
Quality of life Assessed using SF‐36 or FOSQ · adults with obstructive sleep apnoea
1 finding from 1 review
- no estimate extracted1 study · 86 participantsModerate
Positional therapy vs inactive control
Sleep quality Assessed by average duration of slow‐wave and REM sleep periods · adults with obstructive sleep apnoea
1 finding from 1 review
- no estimate extracted1 study · 30 participantsLow
Positional therapy vs inactive control
Cognitive dysfunction · adults with obstructive sleep apnoea
1 finding from 1 review
- no estimate extracted1 study · 86 participantsVery low
Positional therapy vs continuous positive airway pressure (CPAP)
AHI · adults with obstructive sleep apnoea
1 finding from 1 review
- no estimate extracted2 studies · 33 participantsLow
Positional therapy vs continuous positive airway pressure (CPAP)
Self‐reported adherence time · adults with obstructive sleep apnoea
1 finding from 1 review
- no estimate extracted1 study · 20 participantsModerate
Positional therapy vs continuous positive airway pressure (CPAP)
Adverse effects · adults with obstructive sleep apnoea
1 finding from 1 review
- no estimate extracted1 study · 20 participantsGRADE not reported
Positional therapy vs continuous positive airway pressure (CPAP)
Quality of life Assessed using SF‐36 or FOSQ · adults with obstructive sleep apnoea
1 finding from 1 review
- no estimate extracted1 study · 20 participantsLow
Positional therapy vs continuous positive airway pressure (CPAP)
Sleep quality Assessed by average duration of slow‐wave and REM sleep periods · adults with obstructive sleep apnoea
1 finding from 1 review
- no estimate extracted1 study · 13 participantsLow
Positional therapy vs continuous positive airway pressure (CPAP)
Cognitive dysfunction · adults with obstructive sleep apnoea
1 finding from 1 review
- no estimate extracted1 study · 13 participantsGRADE not reported
Positional therapy vs inactive control
Daytime sleepiness (ESS): change from baseline. · adults with obstructive sleep apnoea
1 finding from 1 review
- no estimate extracted2 studies · 187 participantsModerate
Positional therapy vs inactive control
AHI · adults with obstructive sleep apnoea
1 finding from 1 review
- no estimate extracted4 studies · 277 participantsLow
Oral + inhaled dual therapy vs oral monotherapy
Successful treatment of exacerbation: number of participants cured. Outcome assessed on day 42 · bronchiectasis
It is very uncertain whether oral + inhaled dual therapy changes successful treatment of exacerbation: number of participants cured.… compared with oral monotherapy (very low certainty).
1 finding from 1 review
- OR 0.66 [0.22, 2.01]1 study · 53 participantsVery low
Oral + inhaled dual therapy vs oral monotherapy
Successful treatment of exacerbation: number of participants with P aeruginosa eradication. Outcome assessed on day 21 · bronchiectasis
It is very uncertain whether oral + inhaled dual therapy changes successful treatment of exacerbation: number of participants with P… compared with oral monotherapy (very low certainty).
1 finding from 1 review
- OR 2.33 [0.66, 8.24]1 study · 53 participantsVery low
Oral + inhaled dual therapy vs oral monotherapy
Serious adverse events. Outcome assessed on day 42 · bronchiectasis
It is very uncertain whether oral + inhaled dual therapy changes serious adverse events. Outcome assessed on day 42 compared with oral monotherapy (very low certainty).
1 finding from 1 review
- OR 0.48 [0.08, 2.87]1 study · 53 participantsVery low
Oral + inhaled dual therapy vs oral monotherapy
Relapse · bronchiectasis
It is very uncertain whether oral + inhaled dual therapy changes treatment response: relapse (day 42). Outcome assessed on day 42 compared with oral monotherapy (very low certainty).
1 finding from 1 review
- OR 0.57 [0.12, 2.69]1 study · 53 participantsVery low
Oral + inhaled dual therapy vs oral monotherapy
Microbiological response: eradicated. Outcome assessed on day 21 · bronchiectasis
It is very uncertain whether oral + inhaled dual therapy changes microbiological response: eradicated. Outcome assessed on day 21 compared with oral monotherapy (very low certainty).
1 finding from 1 review
- OR 2.4 [0.67, 8.65]1 study · 49 participantsVery low
Oral + inhaled dual therapy vs oral monotherapy
Hospital admissions · bronchiectasis
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Oral + inhaled dual therapy vs oral monotherapy
Death · bronchiectasis
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported